Israeli startup exits have raised $3.8B so far in 2015, more than 2014

Oct. 21, 2015

The first three quarters of 2015 have been a huge achievement for Israel, which has seen $3.8 billion in mergers and acquisitions according to a survey by Israeli financial newspaper Globes.

The survey differentiates between biotech companies and other startups, though combined, that $3.8 billion figure so far this year is $500 million more than in all of 2014. The biggest acquisition in biomed was Valtech Cardio for nearly $1 billion to U.S.-based Heartware. For non medical startups, Annapurna Labs scored $360 million selling itself to Amazon.

The analysis highlights that the grand total over the last 12 years is in the neighborhood of $45 billion worth of cash and stock when looking at value at the time of purchase.

In the public sphere, Lumenis was acquired by a private equity fund for $510 million: This is the largest sale in real money terms, as Valtech Cardio was sold mostly for stock. Management software company ClickSoftware went for $438 million.

For the full item on GeekTime click here.